Find out what you need to know about the week in
cannabis/marijuana news, in 29 minutes!
Don’t forget to subscribe to the Toke TV channel on YouTube.
Toke Signals Radio Bud Pick of the Week
Toke Signals Radio Stories of the Week
In a groundbreaking statement on Thursday, the Epilepsy Foundation called for increased medical marijuana access and research to treat epilepsy.
Patient advocacy group Americans for Safe Access (ASA) on Thursday certified the first two dispensaries in the country for its new nationwide program that verifies the quality and reliability of products sold at licensed medical marijuana businesses. The certifications issued to Berkeley Patients Group and SPARC of San Francisco are based on the Patient Focused Certification (PFC) program, the only nonprofit, third-party certification for the medical marijuana industry based on new quality standards issued by the American Herbal Products Association (AHPA) and the American Herbal Pharmacopeia (AHP).
What's up with California? Despite its reputation as a weed-friendly state and polls showing a majority of residents are ready to legalize marijuana, it looks like it's going to be at least two more years before the Golden State's going to get 'er done.
A bill that would ask Oregon voters if they want to legalize marijuana while leaving the regulations up to the Legislature passed its first committee last Thursday. Senate Bill 1556 passed the Senate Judiciary Committee on a 3-2 vote, with all Democrats supporting it and all Republicans opposing. The bill now goes to the Senate Rules Committee.
The Washington state House just before midnight on Monday approved a measure gutting the state's medical cannabis law, claiming the move is necessary to "bring it into line" with the still-unimplemented legal recreational marijuana market created by Initiative 502.
The Washington State Liquor Control Board (Board) on Wednesday approved staff’s recommendations to limit the number of individual marijuana producer licenses to one (from the previous limit of three) and initially limit production at 70 percent, clearing a path for the agency to begin issuing producer and processor licenses.
Most parents and other patients don't realize they could fight seizures just as effectively with uncarboxylated THC — that is, tetrahydrocannabinolic acid, THC acid or THCA — as they could with CBD. Furthermore, THCA is no more psychoactive than is CBD, thus allaying parental concerns about getting their children high. No psychoactive effects are experienced from THCA that hasn’t been carboxylated to THC.